Sands Capital Life Sciences Pulse Fund II, L.P.
SEC Form 4 insider trading activity
Sands Capital Life Sciences Pulse Fund II, L.P. has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Nov 24, 2025.
On the most recent filing, Sands Capital Life Sciences Pulse Fund II, L.P. is listed as 10% Owner at Inhibikase Therapeutics, Inc. Inside the rolling window, Sands Capital Life Sciences Pulse Fund II, L.P. reported 1 open-market purchase totaling $3.0M in IKT and no open-market sales.
Companies traded
Other insiders at IKT
Insider Buying
$3.0M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Sands Capital Life Sciences Pulse Fund II, L.P. made?
Sands Capital Life Sciences Pulse Fund II, L.P. has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2025.
Which companies does Sands Capital Life Sciences Pulse Fund II, L.P. trade?
Sands Capital Life Sciences Pulse Fund II, L.P. has filed SEC Form 4 disclosures for 1 company, including IKT.
When was Sands Capital Life Sciences Pulse Fund II, L.P.'s most recent SEC Form 4 filing?
Sands Capital Life Sciences Pulse Fund II, L.P.'s most recent SEC Form 4 filing on Tracefour is dated Nov 24, 2025.
What is Sands Capital Life Sciences Pulse Fund II, L.P.'s total buy and sell value in the current window?
Inside the rolling retention window, Sands Capital Life Sciences Pulse Fund II, L.P. bought $3.0M and sold $0 based on SEC Form 4 filings.
What was Sands Capital Life Sciences Pulse Fund II, L.P.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 2,068,965 IKT shares on 2025-11-21, worth $3.0M, per SEC Form 4 filings.